Journal of Young Pharmacists logo
Article

Top 507 India’s High-Cited Papers on Covid-19: A Bibliometric Assessment

1, 2★, 3★ Corresponding author

  1. 1Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh, INDIA.
  2. 2Formerly with CSIR-NISTADS, New Delhi, INDIA.
  3. 3Phcog.Net #17, Cox Town, Bengaluru, Karnataka, INDIA.

CORRESPONDENCE

BM Gupta

Formerly with CSIR-NISTADS, New Delhi, INDIA.

bmgupta1@gmail.com

Received: 20-07-2021; Revised: 09-09-2021; Accepted: 20-10-2021.

Volume 13, Issue 3s · pp. s48-s51 · 2021 · DOI: 10.5530/jyp.2021.13s.70

ABSTRACT

In this paper, we have collected the data about the 507 high-cited (citations ≥ 25) papers on Covid 19 published by India using Scopus database. Within small span of time many papers have received considerable number of citations. Further we have analyzed in terms of types of papers, major funding agencies, major collaborating countries, prolific authors, productive organizations and cluster analysis of author supplied keywords. Most of the papers were Original Artciles. Department of Science and Technology, Govt. of India has funded considerable numbers of papers on Covid 19 and K. Dhama form Indian Veterinary Research Institute has contributed highest numbers papers and USA was major collaborating country and PGIMER-Chandigarh was most contributing organization. This study will be useful to the scientist/researchers to know the characteristics of high cited papers on Covid- 19 from India.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Kolle, S. R., Gupta, B., & Ahmed, K. M. (2021). Top 507 India’s High-Cited Papers on Covid-19: A Bibliometric Assessment. Journal of Young Pharmacists, 13(3s), s48-s51. https://doi.org/10.5530/jyp.2021.13s.70

    Copyright and licence

    © 2021 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0